In the long human effort to prevent heart disease before it strikes, a major clinical trial has arrived at a humbling equivalence: whether physicians used advanced imaging of arterial calcium or time-tested risk calculations to decide who should take cholesterol-lowering statins, the rates of heart attacks and strokes were the same. The CorCal Outcomes trial, presented at the 2026 European Society of Cardiology Congress, enrolled nearly 5,800 patients over four years and found that the path to the destination mattered less than whether patients actually walked it — those shown physical evidenc